Avalo Therapeutics CEO Michael Cola's 2021 pay falls 29% to $2.7M
Avalo Therapeutics reports 2021 executive compensation
By ExecPay News
Published: October 19, 2023
Avalo Therapeutics reported fiscal year 2021 executive compensation information on October 19, 2023.
In 2021, five executives at Avalo Therapeutics received on average a compensation package of $1.5M, a 44% decrease compared to previous year.
Average pay of disclosed executives at Avalo Therapeutics
Michael Cola, Chief Executive Officer, received $2.7M in total, which decreased by 29% compared to 2020. 87% of Cola's compensation, or $2.3M, was in option awards. Cola also received $326K in non-equity incentive plan and $36K in salary.
Schond Greenway, Chief Financial Officer, received a compensation package of $1.7M. 74% of the compensation package, or $1.2M, was in option awards.
H. Jeffrey Wilkins, Chief Medical Officer, earned $1.2M in 2021, a 16% decrease compared to previous year.
Garry Neil, Chief Executive Officer, received $1.2M in 2021.
Christopher Sullivan, Chief Financial Officer, earned $628K in 2021.
Related executives
You may also like
Source: SEC filing on October 19, 2023.